US 8431134
Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen
granted A61KA61K31/00A61K31/53
Quick answer
US patent 8431134 (Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen) held by The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
- Grant date
- Tue Apr 30 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/00, A61K31/53, A61K38/164, A61K38/1725